PRE
PRENETICS GLB (PRE)
NASDAQ
$21.17+$0.20 (+0.95%)
Price as of Jun 03, 2026 6:43 PM EDT
  • N/A
    Market Cap
  • 178.49%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
92.4M
+201.72%
30.6M
+40.83%
21.7M
-92.12%
275.8M
N/A
Cost of Revenue
43.6M
+186.45%
15.2M
+17.88%
12.9M
-91.05%
144.2M
N/A
Gross Profit
48.8M
+216.82%
15.4M
+74.41%
8.8M
-93.29%
131.6M
N/A
Sales and Marketing Expense
35.5M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.1M
-53.02%
-10.9M
-6.33%
-11.7M
-24.86%
-15.5M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
-44.5M
-7.61%
-48.1M
-7.25%
-51.9M
+122.75%
-23.3M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
86,000
+177.42%
31,000
-94.66%
580,440
N/A
N/A
N/A
Income before Taxes
-40.0M
-19.73%
-49.8M
-23.11%
-64.8M
-65.99%
-190.5M
N/A
Income Taxes
34,000
+100.43%
-7.9M
+2,823.24%
-269,359
-103.77%
7.1M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-40.0M
-19.73%
-49.8M
-23.11%
-64.8M
-65.99%
-190.5M
N/A
Net Income from Continuing Operations Applicable to Common
-40.0M
-19.73%
-49.8M
-23.11%
-64.8M
-65.99%
-190.5M
N/A
Basic EPS and Net Income
-2.68
-27.76%
-3.71
-33.51%
-5.58
+123.20%
-2.50
N/A
Diluted EPS and Net Income
-2.68
-27.76%
-3.71
-33.51%
-5.58
+123.20%
-2.50
N/A
Basic Weighted Average Shares
14.1M
+12.46%
12.5M
+11.10%
11.2M
-85.21%
76.0M
N/A
Diluted Weighted Average Shares
14.1M
+12.46%
12.5M
+11.10%
11.2M
-85.21%
76.0M
N/A
Balance Sheet
Cash and Cash Equivalents
32.1M
-38.51%
52.3M
+14.32%
45.7M
-68.84%
146.7M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
32.1M
-38.51%
52.3M
+14.32%
45.7M
-68.84%
146.7M
N/A
Total Current Assets
85.2M
-1.10%
86.1M
-8.02%
93.7M
-61.27%
241.8M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
13.1M
N/A
Total Long-Term Assets
120.9M
-5.14%
127.4M
-20.61%
160.5M
+128.25%
70.3M
N/A
Total Assets
206.1M
-3.51%
213.6M
-15.97%
254.2M
-18.57%
312.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
28.7M
-21.44%
36.6M
-7.43%
39.5M
-30.97%
57.2M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
21.0M
+269.74%
5.7M
+25.36%
4.5M
-60.52%
11.5M
N/A
Total Liabilities
49.7M
+17.71%
42.2M
-4.05%
44.0M
-35.90%
68.7M
N/A
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Stockholders Equity
156.4M
-8.74%
171.3M
-18.47%
210.2M
-13.68%
243.5M
N/A
Total Shares Outstanding
11.4M
-12.18%
13.0M
+6.43%
12.2M
+3,825.04%
310,825
N/A
Cash Flow
Cash from Operating Activities
-21.8M
-24.41%
-28.9M
+109.77%
-13.8M
-194.84%
14.5M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-35.7M
-192.61%
38.5M
+146.46%
-83.0M
+79.77%
-46.1M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
37.5M
+1,220.76%
-3.3M
-28.94%
-4.7M
-103.28%
143.3M
N/A
Financials Ratio
Gross Margin
52.81%
+5.00%
50.29%
+23.84%
40.61%
N/A
N/A
N/A
Operating Margin
-48.14%
-69.38%
-157.23%
-34.14%
-238.73%
N/A
N/A
N/A
Return on Assets
-19.05%
-10.53%
-21.30%
-6.91%
-22.88%
N/A
N/A
N/A
Return on Equity
-24.40%
-6.56%
-26.11%
-8.58%
-28.56%
N/A
N/A
N/A
Revenue Growth
201.72%
+394.01%
40.83%
+144.33%
-92.12%
N/A
N/A
N/A
Current Ratio
2.97
+25.89%
2.36
-0.64%
2.37
N/A
N/A
N/A
Cash Ratio
1.12
-21.72%
1.43
+23.49%
1.16
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow